-o-
glembatumumab
idiospecific
booster shot
immunoantigen
retifanlimab
booster dose
vanucizumab
immunoreactivity
sasanlimab
pozelimab
dinutuximab
ziltivekimab
immunobinding
solitomab
toripalimab
zenocutuzumab
monoclonal
sintilimab
booster injection
muromonab
alloantibody
heterophile
atezolizumab
radioimmunoprecipitation
antiidiotypic
tislelizumab
abagovomab
immunosorbing
monoantibody
olaratumab
-mab
immunofiltration
brolucizumab
polytypic
ravulizumab
serofast
immunosorbance
pidilizumab
countercorrelated
gevokizumab
heteroclitic antibody
ABO antibodies
immunocharacterize
cross-reactivity
gamma globulin
radioimmunoelectrophoresis
xenoimmunization